Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577
Shi, Y., Li, C., O'Connor, S.P., Zhang, J., Shi, M., Bisaha, S.N., Wang, Y., Sitkoff, D., Pudzianowski, A.T., Huang, C., Klei, H.E., Kish, K., Yanchunas, J., Liu, E.C., Hartl, K.S., Seiler, S.M., Steinbacher, T.E., Schumacher, W.A., Atwal, K.S., Stein, P.D.(2009) Bioorg Med Chem Lett 19: 6882-6889
- PubMed: 19896847 
- DOI: 10.1016/j.bmcl.2009.10.084
- Primary Citation of Related Structures:  
3K9X - PubMed Abstract: 
We report the design and synthesis of a novel class of N,N'-disubstituted aroylguanidine-based lactam derivatives as potent and orally active FXa inhibitors. The structure-activity relationships (SAR) investigation led to the discovery of the nicotinoyl guanidine 22 as a potent FXa inhibitor (FXa IC(50)=4 nM, EC(2xPT)=7 microM) ...